Page 68 - EJMO-9-3

Eurasian Journal of
Medicine and Oncology An update on SLE

chronic diseases and their prevalence among the population 42. Tanaka Y, Kusuda M, Yamaguchi Y. Interferons and systemic
of northern borders province (NBP) in Saudi Arabia. lupus erythematosus: Pathogenesis, clinical features, and
J Multidiscip Healthc. 2023;16:1047-1056. treatments in interferon-driven disease. Mod Rheumatol.
2023;33(5):857-867.
doi: 10.2147/JMDH.S401001
doi: 10.1093/mr/roac140
33. Alibrahim B, Sharaheeli J, Alassaf L, Abd-Ellatif EE. Risk
assessment of cardiovascular disease among adults attending 43. Baechler EC, Batliwalla FM, Karypis G, et al. Interferon-
primary healthcare centers in Riyadh City 2015. Cureus. inducible gene expression signature in peripheral blood
2022;14(12):e32503. cells of patients with severe lupus. Proc Natl Acad Sci U S A.
2003;100(5):2610-2615.
doi: 10.7759/cureus.32503
doi: 10.1073/pnas.0337679100
34. Ghamri RA, Alzahrani NS, Alharthi AM, Gadah HJ,
Badoghaish BG, Alzahrani AA. Cardiovascular risk factors 44. Tran DQ. In vitro suppression assay for functional
among high-risk individuals attending the general practice assessment of human regulatory T cells. Methods Mol Biol.
at king Abdulaziz University hospital: A cross-sectional 2013;979:199-212.
study. BMC Cardiovasc Disord. 2019;19(1):268. doi: 10.1007/978-1-62703-290-2_16
doi: 10.1186/s12872-019-1261-6 45. Postal M, Peliçari KO, Sinicato NA, Marini R, Costallat LT,
35. Criswell LA. The genetic contribution to systemic lupus Appenzeller S. Th1/Th2 cytokine profile in childhood-onset
erythematosus. Bull NYU Hosp Jt Dis. 2008;66(3):176-183. systemic lupus erythematosus. Cytokine. 2013;61(3):785-791.
36. International Consortium for Systemic Lupus Erythematosus doi: 10.1016/j.cyto.2012.11.023
Genetics (SLEGEN), Harley JB, Alarcón-Riquelme ME, et al. 46. Longhi MS, Ma Y, Grant CR, et al. T-regs in autoimmune
Genome-wide association scan in women with systemic hepatitis-systemic lupus erythematosus/mixed connective
lupus erythematosus identifies susceptibility variants tissue disease overlap syndrome are functionally defective
in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. and display a Th1 cytokine profile. J Autoimmun.
2008;40(2):204-210. 2013;41:146-151.
doi: 10.1038/ng.81 doi: 10.1016/j.jaut.2012.12.003
37. Barbhaiya M, Costenbader KH. Ultraviolet radiation and 47. McKinley PS, Ouellette SC, Winkel GH. The contributions
systemic lupus erythematosus. Lupus. 2014;23(6):588-595. of disease activity, sleep patterns, and depression to fatigue in
systemic lupus erythematosus. A proposed model. Arthritis
doi: 10.1177/0961203314530488
Rheum. 1995;38(6):826-834.
38. James JA, Kaufman KM, Farris AD, Taylor-Albert E, doi: 10.1002/art.1780380617
Lehman TJ, Harley JB. An increased prevalence of Epstein-
Barr virus infection in young patients suggests a possible 48. Cervera R, Khamashta MA, Font J, et al. Morbidity and
etiology for systemic lupus erythematosus. J Clin Invest. mortality in systemic lupus erythematosus during a 10-year
1997;100(12):3019-3026. period: A comparison of early and late manifestations
in a cohort of 1,000 patients. Medicine (Baltimore).
doi: 10.1172/JCI119856 2003;82(5):299-308.
39. Karpuzoglu E, Zouali M. The multi-faceted influences doi: 10.1097/01.md.0000091181.93122.55
of estrogen on lymphocytes: Toward novel immuno-
interventions strategies for autoimmunity management. 49. Greco CM, Rudy TE, Manzi S. Adaptation to chronic
Clin Rev Allergy Immunol. 2011;40(1):16-26. pain in systemic lupus erythematosus: Applicability of the
multidimensional pain inventory. Pain Med. 2003;4(1):39-50.
doi: 10.1007/s12016-009-8188-0
doi: 10.1046/j.1526-4637.2003.03001.x
40. Gazy NE, Fewings NL, Emerson J, Swaminathan S,
Lee AY, Lin MW. Interferon signatures in systemic lupus 50. Miner JJ, Kim AH. Cardiac manifestations of systemic lupus
erythematosus patients across ethnic groups. Lupus. erythematosus. Rheum Dis Clin North Am. 2014;40(1):51-60.
2023;32(10):1231-1232. doi: 10.1016/j.rdc.2013.10.003
doi: 10.1177/09612033231194211 51. Richter JG, Sander O, Schneider M, Klein-Weigel P.
Diagnostic algorithm for Raynaud’s phenomenon and
41. Vollmer J, Tluk S, Schmitz C, et al. Immune stimulation
mediated by autoantigen binding sites within small nuclear vascular skin lesions in systemic lupus erythematosus.
RNAs involves Toll-like receptors 7 and 8. J Exp Med. Lupus. 2010;19(9):1087-1095.
2005;202(11):1575-1585. doi: 10.1177/0961203310374304
doi: 10.1084/jem.20051696 52. Barile-Fabris L, Hernandez-Cabrera MF, Barragan-

Volume 9 Issue 3 (2025) 60 doi: 10.36922/EJMO025090042